Health & Biotech
Island Pharma closes in on FDA feedback for potential Ebola and Marburg treatment
Growing Pains: Why Australia’s life sciences sector needs patience and capital to scale
Orthocell deepens investment in WA bone-regeneration company Marine Biomedical
Health Check: No sweat as Botanix boosts quarterly revenue and reduces cash burn
PainChek appoints new head of growth to drive Infant App scale-up
Lumos Diagnostics partners with WellStreet Urgent Care to advance FebriDx testing in US
Health Check: Less pain at Mayne after knock-out court win
Aroa posts fourth consecutive quarter of positive net flow with record Myriad sales
Vital Signs Podcast: recognition and global deals boost kidney disease fight
Argenica reports encouraging follow-up results from Phase II stroke study
Trajan’s Mitra tech takes gentler blood testing mainstream
Health Check: Argenica shares flex on follow-up stroke study news
Biocurious: Tag-team leadership helps sleep device maker Somnomed regain its bite
Grant funding boosts EMVision’s rollout of emu brain scanner for regional stroke care
Health Check: The latest ASX biotech IPO is out of the blocks
Health Check: Catapult propels into the soccer talent-scouting big league
Regenerative medicine is a new frontier for medical tech – and these ASX companies are at the forefront
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.
